Table 2:

Observed early and late adverse events for DAH in children with comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children [17]

DAH (n = 143)Ross (n = 3468)Mechanical (n = 799)Allograft (n = 517)
Early death (%)0.703.726.9510.55
Early reintervention (%)4.904.694.202.83
Early stroke (%)0.00.761.450.52
Early pacemaker (%)2.103.173.372.13
Sum of early adverse events (%/year)7.6112.3415.9716.02
Late mortality (%/year)0.400.510.991.38
Any reoperation/intervention (%/year)3.413.421.184.78
Endocarditis (%/year)0.270.370.340.34
Thromboembolism00.130.420.09
Valve thrombosis (%/year)00.190.330.11
Bleeding (%/year)00.090.320.09
Stroke/TIA (%/year)0.140.090.430.11
Sum of late events4.224.804.017.01
DAH (n = 143)Ross (n = 3468)Mechanical (n = 799)Allograft (n = 517)
Early death (%)0.703.726.9510.55
Early reintervention (%)4.904.694.202.83
Early stroke (%)0.00.761.450.52
Early pacemaker (%)2.103.173.372.13
Sum of early adverse events (%/year)7.6112.3415.9716.02
Late mortality (%/year)0.400.510.991.38
Any reoperation/intervention (%/year)3.413.421.184.78
Endocarditis (%/year)0.270.370.340.34
Thromboembolism00.130.420.09
Valve thrombosis (%/year)00.190.330.11
Bleeding (%/year)00.090.320.09
Stroke/TIA (%/year)0.140.090.430.11
Sum of late events4.224.804.017.01

Ross results include right ventricular procedures.

AVR: aortic valve replacement; DAH: decellularized aortic homograft; TIA: Transient ischemic attack.

Table 2:

Observed early and late adverse events for DAH in children with comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children [17]

DAH (n = 143)Ross (n = 3468)Mechanical (n = 799)Allograft (n = 517)
Early death (%)0.703.726.9510.55
Early reintervention (%)4.904.694.202.83
Early stroke (%)0.00.761.450.52
Early pacemaker (%)2.103.173.372.13
Sum of early adverse events (%/year)7.6112.3415.9716.02
Late mortality (%/year)0.400.510.991.38
Any reoperation/intervention (%/year)3.413.421.184.78
Endocarditis (%/year)0.270.370.340.34
Thromboembolism00.130.420.09
Valve thrombosis (%/year)00.190.330.11
Bleeding (%/year)00.090.320.09
Stroke/TIA (%/year)0.140.090.430.11
Sum of late events4.224.804.017.01
DAH (n = 143)Ross (n = 3468)Mechanical (n = 799)Allograft (n = 517)
Early death (%)0.703.726.9510.55
Early reintervention (%)4.904.694.202.83
Early stroke (%)0.00.761.450.52
Early pacemaker (%)2.103.173.372.13
Sum of early adverse events (%/year)7.6112.3415.9716.02
Late mortality (%/year)0.400.510.991.38
Any reoperation/intervention (%/year)3.413.421.184.78
Endocarditis (%/year)0.270.370.340.34
Thromboembolism00.130.420.09
Valve thrombosis (%/year)00.190.330.11
Bleeding (%/year)00.090.320.09
Stroke/TIA (%/year)0.140.090.430.11
Sum of late events4.224.804.017.01

Ross results include right ventricular procedures.

AVR: aortic valve replacement; DAH: decellularized aortic homograft; TIA: Transient ischemic attack.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close